Ribosomes differ between people and that may help explain why we age so differently
Ribosomes are the molecular machines inside every cell that build proteins. They were long thought to work identically in everyone.
Ribosomes are among the most ancient and universal structures in biology. Every living cell has them, and they all do the same job: reading genetic instructions encoded in RNA and assembling proteins from that blueprint. Because the process is so universal and so essential, biologists long assumed ribosomes were effectively identical across individuals — optimized molecular machines with little meaningful variation.
That picture is now being revised. Research discussed in Science describes how ribosomes can differ noticeably between people — not in their basic function, but in their precise composition and their relative efficiency at producing certain proteins. That variation is not random noise; it may contribute to the biological diversity we observe between individuals, including why the same disease affects one person far more severely than another, or why a drug works in one patient and fails in the next.
Variable machines in a universal system
Ribosomes are built from proteins and ribosomal RNA. For decades, it was assumed that all ribosomes in all people were functionally equivalent. More recent research had already begun to complicate that picture, showing that ribosomes in different tissues can have minor compositional differences. But variation between individuals was a further step.
If a person’s ribosomes systematically differ in how efficiently they produce certain proteins, the downstream consequences could be substantial. Proteins are the executors of virtually all biological processes — from immune responses to cellular repair mechanisms. A ribosome that consistently underproduces a particular class of protein, even modestly, could have cumulative effects on health and aging over a lifetime.
What this means for personalized medicine
The finding fits into a broader shift in biomedical science: the recognition that ‘standard’ biological processes are less standardized than assumed. For personalized medicine — tailoring treatments to individual biology — ribosomal variation is a variable currently absent from clinical decision-making. If it partially explains differential responses to drugs that target protein synthesis, that is a gap worth closing.
How large these effects actually are remains an open question. Statistical associations in population studies say little about physiological significance at the level of an individual cell or patient. The mechanism is intriguing, but translating it into clinical relevance will require considerably more work — and more data.